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Abstract
Esophageal cancer, which frequently exhibits coordinated loss of E-cadherin (Ecad) and transforming growth fac-
tor β (TGFβ) receptor II (TβRII), has a high mortality rate. In a three-dimensional organotypic culture model system,
esophageal keratinocytes expressing dominant-negative mutant versions of both Ecad and TβRII (ECdnT) invade
into the underlying matrix embedded with fibroblasts. We also find that cathepsin B induction is necessary for
fibroblast-mediated invasion. Furthermore, the ECdnT cells in this physiological context activate fibroblasts
through the secretion of TGFβ1, which, in turn, is activated by cathepsin B. These results suggest that the interplay
between the epithelial compartment and the surrounding microenvironment is crucial to invasion into the extra-
cellular matrix.
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Introduction
Esophageal cancer carries one of the worst mortality rates of any can-
cer. The prognosis for patients with esophageal squamous cell cancer
remains poor because of the high rate of local and distant metastases
at the time of diagnosis [1]. Critical oncogenes involved in the path-
ogenesis of esophageal squamous cell cancer include cyclin D1 and
epidermal growth factor receptor (EGFR), and key tumor suppressor
genes are TP53, E-cadherin, and TβRII. We previously developed
and characterized an organotypic culture model focusing on p53 mu-
tation in concert with EGFR overexpression, thus leading to the ac-
tivation of stromal fibroblasts and matrix metalloprotease–mediated
degradation of the extracellular matrix [2]. To evaluate other critical
genetic events that are evident in esophageal tumorigenesis, we focus
here on the coordinated loss of E-cadherin (Ecad) and TGFβ recep-
tor type II (TβRII) and elucidate their functional consequences.
Loss of Ecad expression is prominent in epithelial-mesenchymal
transition; therefore, Ecad has emerged as one of the “caretakers” of
the epithelial phenotype [3]. The precise mechanism that underlies
suppression of cell invasion as mediated by Ecad is not well estab-
lished. One possibility is that the adhesive function of Ecad prevents
cells from dissociating from each other and migrating into adjacent
tissues [4,5]. Alternatively, Ecad binds and sequesters β-catenin at
the cell membrane, which regulates the cytoplasmic pool of β-catenin
and, therefore, represents a key mediator in the Wnt signaling pathway
[6]. This function of Ecad is supported by studies in Drosophila and
Xenopus embryos [7–9], which demonstrate that the formation of the
cadherin-catenin complex antagonizes β-catenin signaling function, for
example, during axis formation.
TβRII loss in cancer has been modeled in mice through a dominant-
negative approach in skin [10] and mammary glands [11] as well
as conditional knock-out in the mammary glands [12]. In these mod-
els, mice develop tumors and have a high potential for metastasis,
thereby supporting the tumor-suppressive function of TβRII and intact
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transforming growth factor β (TGFβ) signaling. This is supported fur-
ther by the restoration of wild-type TβRII in colon and breast cancer
cells that lack a functional TGFBR2 allele [13] and by the overexpres-
sion in thyroid carcinomas [14], in which the expression of TβRII
conferred growth inhibition, suppressed anchorage independence,
and abolished tumor formation in nude mice.
In a previous study, we demonstrated the importance of Ecad and
TβRII in esophageal squamous cell cancer because 70% of patient
tumors had coordinated loss of both proteins [15]. To identify the
biological consequences, we have established an organotypic culture
model mimicking the loss of Ecad and TβRII function through the
expression of dominant-negative mutants of both proteins lacking
the cytoplasmic tail in each case. We demonstrate here that esopha-
geal cell invasion is initiated by the epithelial loss of Ecad and TβRII
and is mediated further through cathepsin B induction resulting in
increased levels of TGFβ1.
Materials and Methods
Cell Culture
Primary esophageal epithelial cells (keratinocytes) from normal hu-
man esophagus were established as described previously [15]. Cells
were cultured at 37°C and 5% CO2 in keratinocyte serum-free me-
dium (kSFM) supplemented with 40 μg/ml bovine pituitary extract,
1.0 ng/ml epidermal growth factor, 100 U/ml penicillin, and 100 μg/ml
streptomycin (Gibco, Invitrogen, Carlsbad, CA). Fetal esophageal fibro-
blasts were grown in Dulbecco’s modified Eagle medium (DMEM)
with 10% FBS (Hyclone; Thermo Fisher Scientific, Waltham, MA),
100 U/ml penicillin, and 100 μg/ml streptomycin (Gibco, Invitrogen).
Conditioned media were collected from both esophageal keratinocytes
in kSFM and DMEM and fibroblasts in DMEM with 10% FBS after
72 hours. pGIPZ-shRNAmir constructs against cathepsin B were from
Openbiosystems (Huntsville, AL; available through the Vanderbilt Micro-
array Shared Resource): shRNA#1 corresponds to clone V2LHS151050
with the following sequence: TGCTGTTGACAGTGAGCGAGGT-
GACAATGGCTTCTTTAAATA GTGAAGCCACAGATGTA-
TTTAAAGAAGCCATTGTCACCCTGCCTACTGCCTCGGA,
shRNA#2 is clone V2LHS151051. The sequence is TGCTGTTGACAGT
GAGCGAGCACCGATCAGTACTGGGAAATAGTGAAGCCACA-
GATGTATTTCCCAGTACTTC GGTGCGTGCCTACTGCCT-
CGGA. As a control, the sequence-scrambled, nonsilencing pGIPZ
vector provided by Openbiosystems was expressed.
Tissue Microarrays
The AccuMax Array (ISU ABXIS, Co, Seoul, South Korea) contains
80 esophageal squamous cancer tissues and four normal controls and is
distributed by Accurate Chemical & Scientific Corp (Westbury, NY).
Immunofluorescence staining was performed using anti–cathepsin B
antibody and was scored on a scale from 1 to 4, with 1 being absent and
4 being the highest signal intensity. These scores were compared with
scores from a previous study [15] on a serial section of the same tissue
microarray analyzing the expression of Ecad and TβRII. Scores were
plotted, and linear regression was calculated using Prism4 (GraphPad
Software, Inc, La Jolla, CA). For the statistical analysis of the negative
correlation, we used Spearman correlation.
Organotypic Culture
Organotypic cultures were grown as described previously [16]. In
brief, human esophageal epithelial cells (keratinocytes) were seeded
on day 7 onto a 3:1 collagen I/Matrigel layer with 7.5 × 104 human
fetal esophageal fibroblasts embedded, after the matrix had con-
tracted under the influence of the fibroblasts. Collagen I was pur-
chased from Organogenesis (Canton, MA), and Matrigel Matrix was
purchased from BD Biosciences (Franklin Lakes, NJ). On day 11,
cultures were raised to an air-liquid interface to induce differentiation
of the epithelium. Cultures were harvested on day 15, fixed in 10%
formaldehyde (Fisher, Pittsburgh, PA), and later paraffin-embedded or
directly embedded into OCT for frozen sections. Conditioned media
were collected at the time of harvesting 72 hours after the last medium
change and were either used immediately or snap-frozen and stored at
−80°C. For analysis of the invading areas, ImageJ (NIH, Bethesda,
MD) was used to select areas of invasion and to measure the surface
area for graphic presentation.
Coculture and Transwell Assays
For the coculture, the matrix was prepared as for organotypic cul-
tures with and without fibroblasts and plated into four-well chamber
slides (Falcon, New Brunswick, NJ). The next day, the dominant-
negative mutant versions of both Ecad and TβRII (ECdnT) cells
were plated onto the matrices. In transwell experiments, the bottom
chamber contained fibroblasts, fibroblast-conditioned medium, and
DMEM as control. The transwell insert (pore size, 0.4 μm) was coated
with matrix components as previously mentioned, and ECdnT cells
were plated. All of the cocultures were incubated overnight. After
the methanol/acetone fixation, immunofluorescence staining was per-
formed with anti–cathepsin B, and nuclear counterstain using propi-
dium iodide was performed.
Soft Agar Assay
Soft agar assays were performed as described by Hatziapostolou et al.
[17]. In brief, a 1.5-ml lower layer of 1% agar in 1× DMEM/kSFM
was placed into each well of a six-well culture plate and was allowed
to solidify at room temperature. ECdnT cells, fibroblasts, or cocultures
of both (2.5 × 104 cells total/well) were suspended in a plating layer
of 0.67% agarose in 1 ml of conditioned medium from ECdnT cul-
tures, organotypic cultures, fibroblast cultures, or control kSFM. The
agar was allowed to solidify before incubating the plates at 37°C in a
5% CO2 humidified incubator for 2 weeks. The cells were fed every
48 hours using the appropriate conditioned medium. Colonies were
counted and visualized using the Oxford Optronix Gel Count with
the Gel Count Software, version 1.3 (Oxford, UK), and statistical sig-
nificance was determined using the Student’s t test.
Cell Invasion Assays
Invasion assays were as previously described [15] done using either
8-μm pore size Biocoat Matrigel invasion chambers or Fluoroblok
invasion chambers (BD Biosciences). Inserts were placed in a 24-well
plate containing kSFM, including all supplements or DMEM with
10% FBS as a control for the conditioned medium in the lower
chamber. Conditioned media were collected from fibroblasts growing
in DMEM 10% FBS for 72 hours. Cells (5 × 104 per chamber) were
resuspended in starvation medium and added into each insert. After
overnight incubation, the cells attached to the upper side of the
membrane were removed gently, if necessary, and rinsed. Invading
cells were stained with hematoxylin and eosin for quantification or
with calcein AM (Molecular Probes, Invitrogen) as a fluorescent
dye to count invading cells using a fluorometer (Multimode Plate
Reader Synergy HT; Bio-Tek, Winooski, VT). All experiments were
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done at least in triplicate, and data are presented as mean ±SD. Stu-
dent’s t test was performed for statistical analysis.
Immunohistochemistry/Immunofluorescence
Immunohistochemistry was performed with the Vecta Elite Kit
(Vector Laboratories, Burlingame, CA) following the manufacturer’s
protocol. Briefly, paraffin sections were treated with xylene and then
boiled for 10 minutes in 10 mM citric acid buffer. Endogenous per-
oxidases were quenched using hydrogen peroxide before the sections
were blocked in avidin D–blocking reagent and biotin-blocking re-
agent. The sections were incubated with primary antibody overnight
at 4°C and secondary antibody for 30 minutes at 37°C, and then the
signal was developed using the DAB substrate kit for peroxidase (Vec-
tor Laboratories). For immunofluorescence staining, a biotinylated sec-
ondary antibody was detected using Texas Red—streptavidin (Vector
Laboratories) or fluorescein isothiocyanate–labeled secondary antibody;
stained sections were mounted with 4′,6-diamidino-2-phenylindole
containing mounting medium (Vector Laboratories).
Western Blot Analysis
As described previously [15], subconfluent cells were harvested in
lysis buffer (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% NP-40,
0.1% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 2 mM sodium
orthovanadate, protease inhibitor mixture tablet [Roche Molecular Bio-
chemicals, Indianapolis, IN]). Protein concentration was determined
with the Bio-Rad protein assay (Bio-Rad, Hercules, CA). The solution
was subsequently solubilized in SDS sample buffer containing 10%
β-mercaptoethanol. Total protein samples (20 μg) were separated on
SDS-PAGE gels of appropriate percentage and transferred to a poly-
vinylidene difluoride membrane (Immobilon-P; Millipore, Bedford,
MA). The membranes were blocked in 5% nonfat milk (Bio-Rad)
in 10 mM Tris, 150 mM NaCl (pH 8.0), 0.1% Tween 20 (TBS-T)
for 1 hour at room temperature. The membranes were probed with
the primary antibody diluted in 5% milk in TBS overnight at 4°C,
washed in TBS–Tween 20, incubated with anti-mouse or anti-rabbit
HRP-conjugated antibody (Santa Cruz Biotechnology, Santa Cruz,
CA) diluted 1:3000 in TBS-T for 1 hour at room temperature, and
then washed in TBS-T. The signal was visualized using ECL plus
(GE Healthcare, Buckinghamshire, UK) and exposed to Kodak X-
Omat LS film (Kodak, New York, NY). Experiments were repeated
at least twice.
Reagents and Antibodies
Antibodies recognizing Ki-67 (dilution 1:200), fibronectin (dilu-
tion 1:1000), and vimentin (dilution 1:500) were purchased from BD
Biosciences. α-Smooth muscle actin (α-SMA; 1:500 dilution) and
β-actin (1:5000 dilution) were from Sigma (St Louis, MO), and cathep-
sin B (1:50 for immunofluorescence and 1:5000 for Western blot anal-
ysis) was from Athens Research and Technology (Athens, GA). FSP1
antibody (1:200 dilution) was a gift from Dr Eric Neilson (Vanderbilt
University). The antibodies, ERK1/2 (p42/44) and phospho-p42/44
mitogen-activated protein kinase (MAPK; pERK1/2), were from Cell
Signaling Technology (Danvers, MA). Cathepsin B activity assays
(BioVision, Mountain View, CA) were performed as described in
the manufacturer’s protocol. In brief, cell lysates (data not shown)
and conditioned media were incubated with the reaction buffer in-
cluding substrate for 2 hours at 37°C and, subsequently, were ana-
lyzed using a SpectraMax M5 (Molecular Devices, Sunnyvale, CA)
plate reader at the Molecular Core Facility, Vanderbilt University.
Standardization was based on the number of cells plated in the assay.
In addition, each assay contained 0.2 U of active cathepsin B protein as
a control (BioVision), which was used to calculate and express
the measured cathepsin B activity in the conditioned media samples
in “units.”
ELISA
To determine the concentration of secreted human TGFβ1, the
DuoSet ELISA kit from R&D Systems (Minneapolis, MN) was used.
In brief, conditioned media were activated using 0.1 ml of 1N HCl
and then neutralized before addition to 96-well plates prepared with
the capture antibody, washed, and blocked with 5% Tween in PBS.
The samples and standards were plated in triplicate. After overnight
incubation, the plate was washed, and the detection antibody was
added followed by incubation with the streptavidin–HRP complex.
The developing reaction with substrate was stopped, and the plates
were analyzed subsequently. All experiments were repeated at least
twice. Data are presented ±SD. Student’s t test was performed for sta-
tistical analysis.
Results
Coordinated Loss of Ecad and TβRII Results in
Increased Invasion
We have shown previously that 70% of esophageal squamous cell
cancer tissues harbor concurrent loss of Ecad and TβRII [15]. This
led us to hypothesize that abrogation of Ecad-mediated cell adhesion
in concert with altered TGFβ signaling results in cell invasion during
esophageal tumorigenesis. To test this hypothesis and its biological
consequences, we engineered human primary esophageal keratino-
cytes to express dominant-negative Ecad, EC [15], and dominant-
negative mutant TβRII lacking the cytoplasmic tail (ECdnT) and
compared them with cells expressing full-length wild-type Ecad or
dominant-negative TβRII (dnT) alone. The dominant-negative mu-
tant version of TβRII does not contain the kinase domain [18] and
has been shown to induce increased epithelial branching [19] and
mammary gland hyperplasia [20,21]. Furthermore, dominant-negative
TβRII alters cellular homeostasis [22] and fosters prostrate cancer in
a mouse model [23]. We analyzed ECdnT cells for changes in prolif-
eration as well as for their ability to respond to exogenous TGFβ1.
Whereas Ecad cells exhibited a slower proliferation rate compared with
EC and ECdnT cells, which was diminished further by TGFβ1 stimula-
tion, EC and ECdnT cells did not respond to TGFβ1 (data not shown).
When grown in organotypic culture, in which fibroblasts embed-
ded in Matrigel/collagen form an extracellular matrix with epithelial
cells seeded on top, Ecad cells developed a normal epithelium. By
contrast, a lack of functional Ecad or TβRII resulted in small areas
of invasion by the epithelial cells into the underlying matrix. Dual
loss of Ecad and TβRII in these primary esophageal cells led to an
increased invasive potential (Figure 1).
Cathepsin B Up-regulation in ECdnT Cells Mediates
Epithelial Cell Invasion
Cathepsin B amplification has been associated with esophageal ad-
enocarcinoma and Barrett esophagus [24,25]. Immunofluorescence
staining of an organotypic section with anti–cathepsin B antibody
revealed a more intense fluorescence signal for cathepsin B in organo-
typic cultures of invasive ECdnT cells than control Ecad and EC cells
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(Figure 2A). To evaluate the correlation between the induction of ca-
thepsin B and the coordinated loss of Ecad and TβRII, we analyzed
serial sections of a tissue microarray with normal (n = 4) and squa-
mous cell carcinoma tissues (n = 80 cores from 40 patients). Expres-
sion levels of cathepsin B were scored on a scale from 1 to 4, with 1
being absent and 4 having the highest signal intensity (Figure 2B)
and compared with previous scoring for Ecad and TβRII expression
[15]. Cathepsin B was upregulated in 50 tumor tissues (50/80, 63%)
that had loss of both Ecad and TβRII. In 8 tissue cores, the signal for
Ecad and TβRII was strong, but cathepsin B expression was lost,
whereas the expression pattern of 22 cores demonstrated no correla-
tion. Overall, 58 tissues of 80 or 29 of 40 patients (72%) showed a
statistically significant inverse correlation (P = .0013, ρ = −0.34).
Representative images of immunofluorescence staining highlight-
ing the inverse correlation for Ecad and cathepsin B are shown in
Figure 2B.
A Fibroblast-Secreted Factor Induces Cathepsin B Expression
and the Invasive Potential of ECdnT Cells
To analyze the invasive properties of these cells further, Boyden
chamber invasion assays were used, revealing that ECdnT cells did
Figure 1. ECdnT cells invade into the underlying matrix in organotypic cultures in the presence of fibroblasts. Expression of dominant-
negative mutant versions of Ecad and TβRII resulted in cell invasion into the fibroblast-embedded Matrigel/collagen matrix (C, arrows).
By contrast, Ecad-overexpressing cells show normal epithelium formation (A), whereas expression of mutant Ecad (B; EC) or mutant
TβRII alone (D; dnT) resulted in limited invasive potential (arrows). Hematoxylin and eosin staining of a representative section. Using
ImageJ, invading areas were selected, and surface area was measured and compared. Graphic representation of the measured sum of
invasive areas demonstrated a significant increase in ECdnT cell invasion, *P = .008, ±SD. The suppression of cell invasion by wild-type
Ecad is statistically significant when compared with EC and dnT cells, *P < .001 and ***P = .001, respectively.
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not invade (Figure 3A). Whereas cells lacking Ecad, EC, demon-
strated an increased invasive potential Boyden chamber assays, ECdnT
cells in contrast to their invasive behavior in organotypic cultures did
not invade. This result led us to believe that the extracellular matrix
or the “tumor environment” may be providing cues to the epithelial
compartment for invasion into the matrix to occur.
To address if ECdnT cells could invade in vitro in the presence of a
fibroblast-secreted factor, we performed Boyden chamber invasion as-
says using conditioned media from fibroblasts (Figure 3A) as a chemo-
attractant. In the presence of conditioned media from fibroblasts, but
not unconditioned DMEM (Figure 3A), ECdnT cells were able to
invade through the Matrigel layer.
To analyze the effect of the fibroblast-mediated signaling on ca-
thepsin B expression, we stimulated monolayer Ecad, EC, and
ECdnT cells with fibroblast-conditioned medium and compared ca-
thepsin B expression levels by Western blot (Figure 3B). Not only
Figure 2. Cathepsin B up-regulation inversely correlates with loss of Ecad and TβRII. (A) Cathepsin B (cath B) expression in organotypic
cultures is shown by immunofluorescence staining using anti–cathepsin B antibody. The signal intensity was measured using ImageJ.
(B) Analysis of a tissue microarray with 80 esophageal tumor samples from 40 patients and 4 normal tissues. Tissues were stained and
scored for Ecad, TβRII, and cathepsin B expression. Scores ranged from 1 (absent) to 4 (highest expression). The graphic representation
of the scores demonstrates the linear regression between Ecad/TβRII and cathepsin B expression. Analysis using Spearman correlation
shows a significant negative correlation (P = .0013, ρ = −0.34). Error bars, SEM. Representative pictures of immunofluorescence stain-
ing for cathepsin B and Ecad show no signal for cathepsin B (red, score 1) and a strong signal for Ecad (green, score 4) localizing to the
membrane in normal esophageal epithelium (a). Similarly, a cathepsin B–negative tumor (b; red, score 1) has a strong signal for Ecad (b;
green, score 4, tumor #1), whereas a cathepsin B–positive tumor is Ecad-negative (c; tumor #2). Intermediate expression levels that
correspond to a score of 2 are shown for both molecules (d; tumor #3).
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was the expression of cathepsin B increased, but we also observed
greater activation of latent cathepsin B in ECdnT cells (Figure 3B).
The smaller–molecular weight band corresponds to activated cathep-
sin B (∼30 kDa), and the higher–molecular weight band is recog-
nized as the latent precursor [26].
The up-regulation of cathepsin B has been shown to be regulated by
the MAPK pathway. Through analyzing the phosphorylation status of
p42/44 in ECdnT cells in response to stimulation with fibroblast-
conditioned media, we can show that p42/44 is phosphorylated under
these conditions (Figure 3C). To demonstrate the importance of the
fibroblasts in the induction of cathepsin B, we grew ECdnT cells on
the same matrix as in organotypic cultures with and without em-
bedded fibroblasts (Figure 3D). Immunofluorescence staining with
anti–cathepsin B antibody shows up-regulation of cathepsin B in
ECdnT keratinocytes only when fibroblasts were embedded in the ma-
trix. These data were confirmed in transwell assays in which fibro-
blasts, fibroblast-conditioned media, or control DMEM was added
to the bottom chamber. Again, cathepsin B expression in the ECdnT
epithelial cells was only upregulated in the presence of fibroblasts or
fibroblast-conditioned media (Figure 3E).
To investigate the involvement of cathepsin B in the fibroblast-
dependent invasion of ECdnT cells, we infected ECdnT cells with
lentivirus encoding short hairpin RNA (shRNA) against cathepsin B
and showed a decrease in invasion in Boyden chamber assays (Fig-
ure 3F ) in the presence of fibroblast-conditioned media. When grown
in organotypic cultures, ECdnT cells with suppressed cathepsin B ex-
pression invaded less (Figure 3G ). Immunofluorescence staining with
anti–cathepsin B antibody confirmed the suppression of cathepsin B
expression in organotypic cultures (Figure 3G ). Therefore, we con-
clude that the increased invasive behavior of ECdnT cells is on the
induction of cathepsin B through a fibroblast-secreted factor.
Fibroblasts Are Activated through Cross Talk with Invasive
Epithelial Cells
We performed immunohistochemical staining for several markers
associated with fibroblast activation, for example, vimentin, Ki-67,
FSP1, and α-SMA (Figure 4A). When stained with anti-vimentin
antibody, fibroblasts demonstrated increased expression of vimentin
in invasive cultures (Figure 4A). Vimentin-positive fibroblasts local-
ized closely to the areas of epithelial invasion similar to the observa-
tion made by Gaggioli et al. [27]. Interestingly, ECdnT keratinocytes
also showed a stronger vimentin signal than Ecad and EC cells. Ki-67
staining demonstrated more Ki-67–positive fibroblasts in ECdnT
cultures, whereas Ecad organotypic cultures did not induce prolifera-
tion of fibroblasts (Figure 4B). The number of FSP1-positive fibro-
blasts increased in EC and ECdnT organotypic cultures (Figure 4C),
whereas fibroblasts in all three organotypic cultures were α-SMA–
positive (Figure 4D). The increase in number of FSP1- and vimentin-
positive fibroblasts, together with the observed increase in proliferation,
indicates activation of these fibroblasts in an invasive environment.
To evaluate the premise that fibroblasts may be activated through
a factor secreted by the epithelial cells, we performed experiments
using conditioned media. Treatment with conditioned media from
noninvasive cells, for example, Ecad-overexpressing cells versus inva-
sive ECdnT cells, demonstrated the induction of vimentin, α-SMA,
and FSP1 in fibroblasts only in the invasive microenvironment (Fig-
ure 5A). The suppression of ECdnT cell invasion through infection
with shRNA against cathepsin B results in FSP1-negative fibroblasts
that are less proliferative (Figure 5B, a and b) and express low levels
of vimentin (Figure 5B, c); this is similar to the Ecad control cells in
Figure 4A. As in Figure 4A, fibroblasts in the noninvasive environ-
ment as well as in the invasive environment are α-SMA–positive
(Figure 5B, d ). Furthermore, we analyzed fibroblast expression of
Figure 3. ECdnT cell invasion is mediated by cathepsin B in a fibroblast-dependent manner. (A) Invasion assays using conditioned media
from fibroblasts (fibro CM) demonstrated that ECdnT cells gain properties to invade into Matrigel (black bars) compared with uncondi-
tioned DMEM (gray bars) or unconditioned kSFM (white bars), **P= 2.8 × 10−5. EC cells show significantly increased invasion under all
conditions compared with Ecad, *P = 1.8 × 10−5. Data represent the mean of triplicates, ±SD. This experiment is representative of
three independent replicates. (B) Cathepsin B is upregulated in the presence of fibroblast-conditioned media. Western blot analysis of
ECdnT cells grown in monolayer demonstrates the up-regulation of cathepsin B after a 72-hour treatment with conditioned media from
fibroblasts (fibro CM) compared with lysates harvested after treatment with control media (kSFM and DMEM). In 12% SDS-PAGE, a
higher– and a lower–molecular weight band were detected after growth in kSFM and DMEM, representing latent and active cathepsin B,
respectively. (C) Stimulation of ECdnT cells with fibroblast-conditioned medium (fibro CM) stimulated the phosphorylation of ERK1/2
(p42/44). (D) Cocultures of ECdnT cells with fibroblasts embedded in organotypic culture matrix (a, b, c) or ECdnT cells on matrix alone
(d) were stained with anti–cathepsin B antibody (green) and nuclei were counterstained with propidium iodide to show the up-regulation
of cathepsin B (original magnifications: a and b, ×20; c and d, ×40) in the presence of fibroblasts (b; arrows point to nuclei of the
fibroblasts embedded in the matrix). (E) Anti–cathepsin B immunofluorescence (green) of ECdnT keratinocytes grown in a transwell
show expression of cathepsin B in the presence of fibroblasts in the bottom chamber (a) or fibroblast-conditioned medium (b). Low
levels of cathepsin B can be detected with DMEM in the bottom chamber (c). Original magnification of insets, ×40. (F) Suppression of
cathepsin B using shRNA (shRNA #1 and shRNA #2 are independent clones) resulted in reduced levels of cathepsin B expression as
demonstrated by Western blot of lysates from monolayer culture, and t test highlights significant differences in the invasive potential
(Student’s t test, **P = .007 and ***P = .005) in invasion assays comparing ECdnT cells expressing nonsilencing scrambled vector
control and cathepsin B shRNA. In the presence of fibroblast-conditioned medium (fibro CM, black bars) invasion of cathepsin B shRNA
expressing cells was decreased. The increase in invasion in the presence of fibro CM compared with DMEM control (gray bars) is
statistically significant as determined with two-tailed Student’s t test, *P = .001. Data represent the mean of triplicates, ±SD. This
experiment is representative of three independent replicates. (G) When grown in organotypic cultures, ECdnT cells expressing shRNA
cathepsin invaded less compared with nonsilencing control cells. Immunofluorescence staining demonstrates decreased cathepsin B
signal in the shRNA expressing ECdnT cells. Using ImageJ, invading areas were selected, and the surface area was measured and
compared. Graphic representation of the measured sum of invasive areas demonstrating significant increase in ECdnT cell invasion,
*P = .01, ±SD.
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vimentin and α-SMA grown in monolayer in response to stimulation
with TGFβ1, ECdnT-conditioned media, ECdnT-shRNA cathep-
sin B–conditioned media, and control media to demonstrate the link
between fibroblast activation and invasive ECdnT cells. Fibroblasts are
vimentin-positive in the presence of TGFβ1 and ECdnT-conditioned
media but not in the presence of ECdnT-conditioned media from
cells expressing shRNA against cathepsin B or control media. There
were no differences in α-SMA expression other than slightly lower
levels in fibroblasts stimulated with ECdnT-conditioned medium
(Figure 5C).
Furthermore, we could show that, when grown in soft agar, ECdnT
cells were unable to grow in an anchorage-independent fashion
Neoplasia Vol. 12, No. 6, 2010 Fibroblast and Cathepsin B–Dependent Cell Invasion Andl et al. 491
Figure 3. (continued).
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(Figure 5D). By contrast, fibroblasts alone, in addition to cocultures of
fibroblasts and ECdnT cells, were able to grow in soft agar when stim-
ulated with conditioned media from ECdnT cells or organotypic cul-
tures (Figure 5D).
Cathepsin B and TGFβ1 Are Activated Interdependently
TGFβ1 not only is a key factor in the activation of fibroblasts and
known to promote squamous cancer cell invasion [28] but also has
been linked to cathepsin B because TGFβ1 activity can be regulated
by cathepsin B [29,30]. To investigate the link between the up-
regulation of cathepsin B and the secretion of TGFβ1 in ECdnT
cells, we performed ELISA with conditioned media collected from
noninvasive and invasive organotypic cultures. This analysis dem-
onstrates increased levels of TGFβ1 in ECdnT cells, potentially in-
duced to compensate for the disruption of TGFβ signaling through
the expression of dominant-negative TβRII (Figure 6A). The levels of
TGFβ1 secretion were elevated in monolayer ECdnT cells when
grown on collagen (Figure 6B) or after treatment with conditioned me-
dia from fibroblast cultures (Figure 6C). This increase correlated with
an increase in cathepsin B activity in response to collagen extracellular
matrix (Figure 6B, lower panel ) or treatment of monolayer ECdnT
cells with fibroblast-conditioned medium (Figure 6C , lower panel ).
Discussion
Esophageal squamous cell cancer patients harbor high mortality rates
because of the invasive and metastatic nature of this disease. We
demonstrate the importance of the tumor microenvironment in
Figure 4. Fibroblasts in the presence of invasive ECdnT cells express markers of activated fibroblasts. A panel of markers detecting
activated fibroblasts identifies (A) vimentin-positive, proliferating (B), and FSP1-positive (C) cells in ECdnT organotypic cultures, whereas
fibroblasts in all cultures were α-SMA–positive (D). Gray demarcations (C) show basal membrane of the epithelium and invasive areas.
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Figure 5. Conditioned medium from ECdnT cultures induces activation and anchorage-independent growth of fibroblasts. (A) Fibroblasts
show upregulated levels of vimentin, α-SMA, and FSP1/S100 when stimulated with ECdnT-conditioned medium compared with condi-
tioned medium from Ecad and EC cells as shown by Western blot. Cathepsin B shRNA expression results in the suppression of vimentin
and FSP1 in fibroblasts in organotypic cultures (B) and monolayer (C). (B) Ki-67 (a, arrows), FSP1 (b, arrows), and vimentin (c) were not
detected in fibroblasts in the presence of cathepsin B suppression in noninvasive cultures, whereas α-SMA was expressed in fibroblasts
from all cultures. (C) Western blot analysis of fibroblasts grown in the presence of ECdnT-conditioned media, ECdnT-shRNA cathep-
sin B–conditioned media, and TGFβ1 shows up-regulation of vimentin (top arrow) in response to TGFβ1 and ECdnT-conditioned media,
whereas control media (kSFM) and media from organotypic cultures with cathepsin B suppression did not induce vimentin. α-SMA is
present under all conditions (bottom arrow), although lower levels are detected in ECdnT-conditioned media. (D) Fibroblasts (black bars)
and fibroblast/ECdnT cocultures (gray bars) grown in soft agar in the presence of ECdnT-conditioned media (*P = .05) and organotypic
(OTC)-conditioned media (**P = .05 and ***P = .17, not statistically significant) formed a higher number of colonies compared with
those grown in kSFM. ECdnT cells alone lack the ability to grow anchorage-independent (white bars). Fibroblast-conditioned medium
alone did not induce the ability for anchorage-independent growth in any of the cell lines.
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supporting esophageal cell invasion that is mediated through the
induction of cathepsin B in the genetic background of mutations
in Ecad and TβRII.
Role of Cathepsin B in Cell Invasion
The role of cathepsins in cancer cell invasion has recently drawn
attention because of their multiple functions on extracellular matrix
remodeling, regulation of protease activation, and cleavage of cell
adhesion molecules [31,32]. Elevated levels of cathepsin B have
been linked to poor prognosis in lung, breast, head and neck, esoph-
ageal adenocarcinoma, colon, and other cancers [24,33,34]. Studies
detected increased levels of cathepsin B in aggressive pancreatic tu-
mors [35]. Krueger et al. identified cathepsin B up-regulation to be
mediated by the MAPK and p38 signaling pathways using multi-
cellular tumor spheroid cocultures of colon cancer cells, fibroblasts,
and monocytic cells [36]. Although we did not detect activation of
p38 MAPK, we observed phosphorylation of ERK1/2 (Figure 3B).
In vitro studies using Matrigel invasion assays established cathepsin B
to be necessary in cell motility and invasion through small interfer-
ing RNA and chemical inhibitors [37–40]. Our studies, however,
demonstrate that the up-regulation of cathepsin B alone does not
confer the ability for increased cell migration but is dependent on
the tumor microenvironment.
Mechanisms of Cathepsin B Regulation
The mechanisms of cathepsin B up-regulation are twofold: 1) in-
creased cathepsin B expression as observed in the organotypic model
and in the tumor tissues and 2) augmented cathepsin B activity based
on posttranslational processing as seen in Western blot analysis after
conditioned media transfer. Cathepsin B has been noted to be a target
of Hedgehog signaling and is associated with enhanced invasiveness
of pancreatic cancer [41]. A model of the tumor microenvironment
analyzed the effects of nitric oxide on cathepsin B expression [42], with
the finding that cathepsin B is downregulated in response to endothe-
lial nitric oxide synthase and cell invasion is suppressed. Increased lev-
els of cathepsin B have been attributed to changes in TGFβ/BMP
signaling, mainly stimulation with TGFβ1 in the presence of Smad1
reduction as has been reported in myeloid tumors [43].
Posttranslational regulation of cathepsin B has centered on the con-
version of latent to active cathepsin B protein. A study in glioblastoma
showed an increase in cathepsin B activity to be a key regulator of
cell invasion using synthetic inhibitors and genetic knock-down ap-
proaches [44]. Another mechanism involved in the processing of ma-
ture forms of cathepsin B is in the presence of tumor cells in contact
with collagen I [45]. In contrast, collagen type II enhances messenger
RNA expression of cathepsin B in chondrocytes after induction of pro-
tein kinase C and p38 MAPK [46]. Taken together, the mechanisms
underlying cathepsin B activation highlight the role of cathepsin B in
cancer cell invasion.
Link between Cathepsin B and TGFβ1
We show that the up-regulation of cathepsin B activity correlates
with an increase in TGFβ1 concentration in conditioned media of
ECdnT cells (Figure 6). The increase in cathepsin B secretion and ac-
tivity stimulated by collagen has been observed previously [47]. We
conclude that the extracellular matrix might aid in the up-regulation
of cathepsin B, and cathepsin B, in turn, might increase the levels
of activated TGFβ1. Furthermore, the up-regulation of cathepsin B
expression and activity induced by fibroblast-conditioned media con-
firmed the association of cathepsin B and TGFβ1. TGFβ1 is secreted
in a latent form and activated through cleavage after secretion, and
exocytosis of cathepsin B activates TGFβ1 [30]. In another model sys-
tem using Leishmania chasagi, TGFβ1 release from the latent complex
was dependent on cathepsin B activity [29]. Activated TGFβ1 will
then signal to fibroblasts resulting in their activation and the observed
epithelial cell invasion.
Fibroblast Activation through ECdnT Cells
The tumor stroma is an important regulator of cancer progression
[48,49]. Malignant transformation can be induced in nontumori-
genic epithelia through cancer-associated fibroblasts [50,51]. In our
study, fibroblasts in organotypic cultures, whether with invasive or
noninvasive phenotypes, stained positive for α-SMA. However, the
expression of FSP1 and vimentin was increased only in organotypic
cultures with more invasive epithelial cells. FSP1 and α-SMA are
markers for activated fibroblasts [49]. Furthermore, the expression
of FSP1 together with an increase in proliferation as measured by
Ki-67 demonstrates that the fibroblasts in coculture with invasive ep-
ithelial cells are activated. FSP1 is a lineage marker for fibroblasts and
a potential marker for cells undergoing epithelial-mesenchymal tran-
sition and acquiring the capacity for increased motility [52,53]. In
addition, metastatic carcinoma cells are less likely to form tumors
and to metastasize when injected into FSP1−/− mice [54]. To restore
tumor formation and metastasis, Grum-Schwensen et al. [54] coin-
jected the carcinoma cells with FSP1+/+ and FSP1−/− fibroblasts, sup-
porting the notion that FSP1-positive fibroblasts are necessary for
invasive tumor growth. TGFβ1 can induce the transition from fibro-
blasts to myofibroblasts and the activation of cancer-associated fibro-
blasts [49].
Figure 5. (continued).
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Overall, we show here a model of cathepsin B–mediated invasion
of epithelial cells induced by cues from activated fibroblasts. This
study demonstrates the importance of epithelial-mesenchymal com-
munication and point to secreted factors as the key factors orchestrat-
ing the delicate balance between normal and invasive cell fate.
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Figure 6. Increased TGFβ1 secretion correlates with cathepsin B activity in ECdnT cells. (A) Conditioned media from organotypic cultures
when analyzed by ELISA have statistically significant increased levels of TGFβ1 secretion as determined using Student’s t test, *P =
.0009. Data presented are mean values of triplicates, ±SD. This experiment is representative of three replicates. (B) TGFβ1 concentration
was measured in conditioned media using ELISA and determined by Student’s t test to be significantly increased when cultured on
collagen (collagen, black bar) compared with plastic (black bar), *P = .002. At the same time, cathepsin B activity was upregulated
in conditioned media collected from collagen cultures (black bar) compared with conditioned medium from plastic cultures, **P =
.008. Data presented are mean values of triplicates, ±SD. This experiment is representative of three replicates. (C) Analysis of con-
ditioned media by ELISA demonstrated TGFβ1 secretion (upper panel) in monolayer ECdnT cells to be elevated in the presence of
fibroblast-conditioned media (fibro CM, black bar) compared with unconditioned control medium, DMEM (gray bar), *P = 1.8 × 10−6.
t Test highlights significant up-regulation of cathepsin B (lower panel) activity in the presence of fibroblast-conditioned medium compared
with control medium (unconditioned DMEM medium), **P = .0006. Data presented are mean values of triplicates, ±SD. This experiment
is representative of three replicates.
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